These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 2162036
21. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig. Robberecht P, Tatemoto K, Chatelain P, Waelbroeck M, Delhaye M, Taton G, De Neef P, Camus JC, Heuse D, Christophe J. Regul Pept; 1982 Oct; 4(5):241-50. PubMed ID: 6294750 [Abstract] [Full Text] [Related]
22. High-affinity binding sites for VIP in renal cortical membranes: possible role of VIP in renal transport. Kniaz D, Pahlavan P, Valaitis D, Arruda JA. Kidney Int; 1991 Feb; 39(2):266-72. PubMed ID: 1848330 [Abstract] [Full Text] [Related]
23. High affinity receptors for vasoactive intestinal peptide on a human glioma cell line. Nielsen FC, Gammeltoft S, Westermark B, Fahrenkrug J. Peptides; 1990 Feb; 11(6):1225-31. PubMed ID: 1965033 [Abstract] [Full Text] [Related]
25. Molecular characteristics and peptide specificity of vasoactive intestinal peptide receptors from rat cerebral cortex. Couvineau A, Gammeltoft S, Laburthe M. J Neurochem; 1986 Nov 13; 47(5):1469-75. PubMed ID: 3020175 [Abstract] [Full Text] [Related]
26. Characterization of vasoactive intestinal peptide pituitary membrane receptors in turkey hens during different stages of reproduction. Rozenboim I, el Halawani ME. Biol Reprod; 1993 May 13; 48(5):1129-34. PubMed ID: 8386944 [Abstract] [Full Text] [Related]
27. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 1. Molecular characterization of the binding site. Luis J, Martin JM, el Battari A, Reynier M, Marvaldi J, Pichon J. Eur J Biochem; 1989 Mar 15; 180(2):429-33. PubMed ID: 2538330 [Abstract] [Full Text] [Related]
28. Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase. Besson J, Malassiné A, Ferré F. Regul Pept; 1987 Nov 15; 19(3-4):197-207. PubMed ID: 2829291 [Abstract] [Full Text] [Related]
29. Vasoactive intestinal polypeptide regulation of rabbit renal adenylate cyclase activity in vitro. Griffiths NM, Simmons NL. J Physiol; 1987 Jun 15; 387():1-17. PubMed ID: 3656172 [Abstract] [Full Text] [Related]
30. Vasoactive intestinal peptide and its receptors in fetuses with cystic fibrosis. Chastre E, Bawab W, Faure C, Emami S, Muller F, Boué A, Gespach C. Am J Physiol; 1989 Oct 15; 257(4 Pt 1):G561-9. PubMed ID: 2552825 [Abstract] [Full Text] [Related]
31. High affinity peptide histidine isoleucine-preferring receptors in rat liver. Paul S, Chou J, Kubota E. Life Sci; 1987 Nov 23; 41(21):2373-80. PubMed ID: 2824950 [Abstract] [Full Text] [Related]
32. Distribution and characterization of vasoactive intestinal polypeptide binding in canine lower esophageal sphincter. Mao YK, Wang YF, Daniel EE. Gastroenterology; 1993 Nov 23; 105(5):1370-7. PubMed ID: 8224641 [Abstract] [Full Text] [Related]
33. Characterization of vasoactive intestinal peptide receptors in rat seminal vesicle. Guijarro LG, Rodriguez-Pena MS, Prieto JC. Am J Physiol; 1991 Feb 23; 260(2 Pt 1):E286-91. PubMed ID: 1847588 [Abstract] [Full Text] [Related]
34. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes. Wanke IE, Rorstad OP. Endocrinology; 1990 Apr 23; 126(4):1981-8. PubMed ID: 2156675 [Abstract] [Full Text] [Related]
35. Solubilization of rat lung vasoactive intestinal peptide receptors in the active state. Characterization of the binding properties and comparison with membrane-bound receptors. Patthi S, Simerson S, Veliçelebi G. J Biol Chem; 1988 Dec 25; 263(36):19363-9. PubMed ID: 2848823 [Abstract] [Full Text] [Related]
36. Characterization and solubilization of vasoactive intestinal peptide receptors from rat lung membranes. Provow S, Veliçelebi G. Endocrinology; 1987 Jun 25; 120(6):2442-52. PubMed ID: 3032591 [Abstract] [Full Text] [Related]
37. Characterization of vasoactive intestinal peptide receptors in retina. Swedlund AP, Rosenzweig SA. Exp Eye Res; 1990 Sep 25; 51(3):317-23. PubMed ID: 2169429 [Abstract] [Full Text] [Related]
38. Characterization of functional receptors for vasoactive intestinal peptide (VIP) in rat peritoneal macrophages. Segura JJ, Guerrero JM, Goberna R, Calvo JR. Regul Pept; 1991 Apr 25; 33(2):133-43. PubMed ID: 1652777 [Abstract] [Full Text] [Related]
39. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29. Couvineau A, Rousset M, Laburthe M. Biochem J; 1985 Oct 01; 231(1):139-43. PubMed ID: 2998337 [Abstract] [Full Text] [Related]
40. [Autoradiographic localization and characterization of the ocular binding sites of the VIP (vasoactive intestinal peptide) in albino rats and rabbits]. Denis P, Dussaillant M, Elena PP, Nordmann JP, Rostene W, Laroche L. Ophtalmologie; 1990 Oct 01; 4(1):30-2. PubMed ID: 2174530 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]